Influence of Cell Cycle Checkpoints and p53 Function on the Toxicity of Temozolomide in Human Pancreatic Cancer Cells

Publisher： Karger

E-ISSN： 1424-3911|10|5|565-579

ISSN： 1424-3903

Source： Pancreatology, Vol.10, Iss.5, 2010-10, pp. : 565-579

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Downregulation of Nucleostemin Causes G1 Cell Cycle Arrest via a p53-Independent Pathway in Prostate Cancer PC-3 Cells

By  

Urologia Internationalis, Vol. 85, Iss. 2, 2010-07 ,pp. : 221-227

Karger

Access to resources Recommend Favorite

Adenovirus p53 Purging for Human Breast Cancer Stem Cell Products

By  

Acta Haematologica, Vol. 101, Iss. 2, 1999-04 ,pp. : 97-105

Karger

Access to resources Recommend Favorite

Enhancement of Gemcitabine-Induced Apoptosis by Restoration of p53 Function in Human Pancreatic Tumors

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 179-189

Karger

Access to resources Recommend Favorite

The natural anticancer compound rocaglamide selectively inhibits the G1‐S‐phase transition in cancer cells through the ATM/ATR‐mediated Chk1/2 cell cycle checkpoints

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 134, Iss. 8, 2014-04 ,pp. : 1991-2002

John Wiley & Sons Inc

Access to resources Recommend Favorite

Deregulation of Cell Cycle Machinery in Pancreatic Cancer

By  

Pancreatology, Vol. 7, Iss. 4, 2007-08 ,pp. : 373-377

Karger

Access to resources Recommend Favorite